The estimated Net Worth of William P Forbes is at least $138 Tausend dollars as of 19 July 2024. William Forbes owns over 3,875 units of Beyond Air stock worth over $38,399 and over the last 5 years he sold XAIR stock worth over $0. In addition, he makes $99,190 as Independent Director at Beyond Air.
Sign up
William Forbes XAIR stock SEC Form 4 insiders trading
William has made over 8 trades of the Beyond Air stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 3,875 units of XAIR stock worth $1,499 on 19 July 2024.
The largest trade he's ever made was buying 50,000 units of Beyond Air stock on 16 November 2023 worth over $47,000. On average, William trades about 6,882 units every 117 days since 2019. As of 19 July 2024 he still owns at least 99,249 units of Beyond Air stock.
You can see the complete history of William Forbes stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Forbes biography
Dr. William P. Forbes Pharm.D. serves as Independent Director of the Company. He brings to the Beyond Air Board more than 30 years of pharmaceutical product development experience and, working with health authorities in the US and Europe, has contributed to numerous marketing approvals spanning a diverse range of therapeutic areas. Dr. Forbes currently serves as the founder, President and Chief Executive Officer of Vivelix Pharmaceuticals, Ltd., a clinical-stage pharmaceutical company focused on gastrointestinal diseases since 2016. Prior to founding Vivelix, Dr. Forbes was at Salix Pharmaceuticals as the Chief Development Officer and also Head of Medical and R&D. Prior to Salix, Dr. Forbes spent 15 years in Clinical Development & Regulatory Affairs and Clinical Research at a number of global pharmaceutical companies.
What is the salary of William Forbes?
As the Independent Director of Beyond Air, the total compensation of William Forbes at Beyond Air is $99,190. There are 8 executives at Beyond Air getting paid more, with Steven Lisi having the highest compensation of $2,969,660.
How old is William Forbes?
William Forbes is 57, he's been the Independent Director of Beyond Air since 2018. There are 4 older and 8 younger executives at Beyond Air. The oldest executive at Beyond Air, Inc. is Michael A. Gaul, 65, who is the Sr. VP of Operations.
What's William Forbes's mailing address?
William's mailing address filed with the SEC is 4242 CAMPUS POINT COURT, SUITE 200, , SAN DIEGO, CA, 92121.
Insiders trading at Beyond Air
Over the last 5 years, insiders at Beyond Air have traded over $4,582,444 worth of Beyond Air stock and bought 3,519,117 units worth $12,396,434 . The most active insiders traders include Robert Carey, Steven A. Lisi und Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of $15,492. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth $18,500.
What does Beyond Air do?
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
What does Beyond Air's logo look like?
Complete history of William Forbes stock trades at Heron Therapeutics Inc, Beyond Air und Trevi Therapeutics
Beyond Air executives and stock owners
Beyond Air executives and other stock owners filed with the SEC include:
-
Steven Lisi,
Chairman of the Board, Chief Executive Officer -
Amir Avniel,
President, Chief Operating Officer, Director -
Adam Newman,
Chief Legal Officer and General Counsel -
Steven Adam Lisi,
CEO & Chairman -
Duncan Fatkin,
Chief Commercial Officer -
Douglas Beck,
Chief Financial Officer -
Amir Avniel,
Co-Founder, Pres, COO & Director -
Douglas J. Beck CPA, CPA,
Consultant -
William Forbes,
Independent Director -
Erick Lucera,
Independent Director -
Robert Carey,
Independent Director -
Yoori Lee,
Independent Director -
Ron Bentsur,
Independent Director -
Bob Yedid,
IR Contact Officer -
Prof. Andrew R. Colin M.D.,
Chief Medical Officer & Member of Scientific Advisory Board -
Kori-Ann Taylor,
Head of Marketing -
Rebecca Van Doren,
Head of Sales -
Maria Yonkoski,
Head of Investor Relations -
Douglas Quinton Larson,
CFO, Principal Financial Officer & Principal Accounting Officer -
Hila Confino Ph.D.,
Research Project Mang. -
Michael A. Gaul,
Sr. VP of Operations -
Ali Ardakani,
Sr. VP of Device & Bus. Devel. -
Dr. Giora Davidai M.D.,
Chief Medical Officer -
Douglas Quinton Larson,
Chief Financial Officer -
Michael A. Gaul,
Chief Operating Officer -
Jeff Lynn Myers,
Chief Medical Officer